Compare RLAY & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | INOD |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2020 | 1996 |
| Metric | RLAY | INOD |
|---|---|---|
| Price | $9.59 | $36.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $16.86 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 2.5M | 769.9K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | 3.37 |
| EPS | N/A | ★ 0.92 |
| Revenue | $15,355,000.00 | ★ $86,775,000.00 |
| Revenue This Year | N/A | $35.60 |
| Revenue Next Year | $324.03 | $29.67 |
| P/E Ratio | ★ N/A | $44.50 |
| Revenue Growth | ★ 53.44 | 9.84 |
| 52 Week Low | $1.78 | $26.70 |
| 52 Week High | $11.49 | $93.82 |
| Indicator | RLAY | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 29.97 |
| Support Level | $9.06 | $36.29 |
| Resistance Level | $11.46 | $52.34 |
| Average True Range (ATR) | 0.63 | 2.19 |
| MACD | -0.12 | -0.27 |
| Stochastic Oscillator | 16.18 | 11.04 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.